Obesity specialist Sandra Christensen, MSN, ARNP, compares the benefits and drawbacks among older antiobesity drugs and newer GLP-1RAs liraglutide and semaglutide 2.4 mg.
In a recent interview with Patient Care Online, medical weight management specialist Sandra Christensen, MSN, ARNP, was asked the following question:
Ms Christensen discusses how the different classes of antiobesity medications compare in cost, side effect profiles, and more in the video below.
For a primer on common antiobesity medications, check out part 1 of our interview with Ms Christensen: Antiobesity Medications: Expert Discusses Older, Newer Therapies
Sandra Christensen, MSN, ARNP, is the owner of Integrative Medical Weight Management in Seattle, Washington.